pentobarbital will minimize the extent or impact of buprenorphine, very long-performing injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Individuals who transfer to buprenorphine very long-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers must be monitored to be